Episurf Medical invites to a Capital Markets Day, November 16, 2022

EPISURF MEDICAL AB invites investors, analysts and media to a Capital Markets Day in Stockholm on Wednesday, November 16, 2022 at 13.00-16.00.

Presentations will be held by members of Episurf Medical’s management group and customers, focusing on the company’s global commercial opportunities and strategy for the coming years. Presenters will be CEO Pål Ryfors, COO Katarina Flodström, President of Episurf Medical Inc. Patrick Jamnik, and Head of Sales OUS Stephen Caswell. They will be joined by Associate Professor Tim Spalding who is involved in studies on the Episealer® technology, and Priv.-Doz. Dr. med. Clemens Kösters.

Date: 16 November 2022
Time: 1:00 p.m. to 4:00 p.m
Place: Redeye, Mäster Samuelsgatan 42, Stockholm

There will be physical slots available. For physical slots please register at: https://www.lyyti.fi/reg/Capital_Markets_Day_Episurf_0954

Follow the event digitally at: www.redeye.se        

Welcome!

For more information, please contact:

Pål Ryfors, CEO, Episurf Medical
Tel:+46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

Veronica Wallin, CFO, Episurf Medical
Tel:+46 (0) 700 37 48 95
Email: veronica.wallin@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and individualised treatment alternatives. Episurf Medical’s Episealer® individualised implants and Epiguide® surgical drill guides are developed for treating localised cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.

Tags: